AnaptysBio shareholders elect three Class I directors and approve equity plan amendment at 2024 annual meeting

ANAPTYSBIO, INC

Daniel Faga, Dennis Fenton, and Oleg Nodelman elected as Class I directors with 22.3M, 21.9M, and 18.8M votes for, respectively.
Ratification of KPMG as independent auditor for FY 2024 approved with 24.7M shares for, 30k against.
Non-binding advisory vote on executive compensation passed with 19.9M for, 2.95M against.
Amendment and restatement of 2017 Equity Incentive Plan approved with 16.8M for, 4.7M against, 1.3M abstentions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.